Bendamustine 100mg Injection

Bendamustine 100mg is an alkylating chemotherapy medicine for selected chronic lymphocytic leukaemia and indolent B-cell non-Hodgkin lymphoma regimens.
The prepared medicine is given by intravenous infusion on the scheduled cycle days. Infusion time and dilution depend on the formulation. Report burning or swelling at the cannula immediately.
Bendamustine forms cross-links in DNA, disrupting replication and triggering death of susceptible malignant lymphoid cells.
Low blood counts, infection, fatigue, nausea, vomiting and infusion reactions can occur. Severe skin reactions and tumour-lysis syndrome are important serious risks.
Blood counts and liver and kidney function guide treatment. Infection risk can persist after treatment because lymphocytes recover slowly. Allopurinol can increase concern about severe skin reactions when combined with bendamustine.
Reducing abnormal lymphoid cells can control disease burden and improve response within an appropriate chemotherapy regimen.
Lymphocyte suppression may persist for months. Antiviral or other infection-prevention treatment may therefore continue beyond chemotherapy.
No. Fever can also indicate infection during low blood counts and needs prompt assessment.
Rapid cancer-cell breakdown releases electrolytes and waste products, potentially affecting kidneys and heart rhythm.
Yes. Ready-to-dilute solutions and powder formulations can differ in preparation and infusion instructions.
Alkylating agent: medicine that chemically damages DNA. Indolent lymphoma: a generally slower-growing lymphoma. Tumour lysis: rapid breakdown of malignant cells.; AR: Bendamustine 100mg حقن; FR: Bendamustine 100mg injection; PT: Bendamustine 100mg injeção; ES: Bendamustine 100mg inyección; RU: Bendamustine 100mg инъекция; ID: Bendamustine 100mg suntikan; VI: Bendamustine 100mg thuốc tiêm; MS: Bendamustine 100mg suntikan; TL: Bendamustine 100mg iniksyon; ZH-SG: Bendamustine 100mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Bendamustine 100mg Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Bendamustine 100mg Injection